Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (ATYR)
NASDAQ:ATYR
Efzofitimod 450 Mg, Efzofitimod 270 Mg
Interstitial Lung Disease
Phase II
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
May 12, 2023
―
Efzofitimod 3 Mg/Kg, Efzofitimod 5 Mg/Kg
Pulmonary Sarcoidosis
Phase III
Active Not Recruiting
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
Jun 08, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does aTyr Pharma (ATYR) have in its pipeline
ATYR is currently developing the following drugs: Efzofitimod 450 Mg, Efzofitimod 270 Mg, Efzofitimod 3 Mg/Kg, Efzofitimod 5 Mg/Kg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.